Sweden· SE-20171102000145

Octreotide Teva 10 mg Pulver och vätska till injektionsvätska, depotsuspension

A octreotide product containing octreotide acetate, registered in Sweden by Teva B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC H01CB02

Checked against Swedish Medical Products Agency (Sweden) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about octreotide acetateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Octreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB02 (octreotide), each read from that country’s own register.

This record: Sweden, from Swedish Medical Products Agency (Sweden)
10 of them publish a price we can compare per daily dose

Search octreotide products by name

Octreotide · ATC H01CB02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of octreotide costs, country by country.

Normalised to the WHO defined daily dose (0.7 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Octreotide · price per daily dose (0.7 mg)

USD · FX 28 Sept 2026

CH Switzerland$41.46

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)

Active substance: Octreotide Acetate
Manufacturer: Teva B.V.
Country: Sweden (SE)
ATC code: H01CB02
ATC class: Octreotide
Defined daily dose: 0.7 mg, P
Reimbursed: Not published by this register
Source register: Swedish Medical Products Agency (Sweden)
Last checked: October 1, 2026

Packs & prices · 1

se_varunummer
20171102000145

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for octreotide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check octreotide against other medicines How interaction checks work

Octreotide · interactions on record

367 records

4 severe
151 moderate
4 minor
168 info

Most severe, free to view

LonafarnibA16AX20severe
PexidartinibL01EX15severe
BexaroteneL01XF03severe
BexarotenL01XX25severe

40 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Octreotide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octreotide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Octreotide Ratiopharm, Sandostatin
Belgium · Octreoteva Long Acting, Octreotide Qilu
Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
Cyprus · Octreotide Rompharm, Sandostatin
Czechia · Octreotide Teva, Octreotide Teva B.V.
Germany · Octreo Ratiopharm, Octreotid Bendalis
Denmark · Octreoanne, Octreotid Sun
Estonia · Octreotide Teva, Sandostatin
Spain · Octreotida Gp-Pharm, Octreotida Sun
Finland · Octreotide Orion, Octreotide Ratiopharm
France · Octreotide Arrow, Octreotide Hospira
United Kingdom (Northern Ireland) · Octreotide Chemi, Octreotide Hospira Uk
Greece · Okrodin, Sandostatin
Croatia · Oktreotid Teva, Sandostatin
Hungary · Oktreotid Teva, Sandostatin
Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
Iceland · Octreoanne, Oczyesa
Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
Liechtenstein · Oczyesa
Lithuania · Octreotide Teva, Sandostatin
Luxembourg · Octreoteva Long Acting, Sandostatine
Latvia · Sandostatin, Sandostatin Lar
Malta · Sandostatin, Sandostatin Lar
Netherlands · Octreotide Bendalis, Octreotide Depot Teva
Norway · Octreoanne, Octreotide Orion
Poland · Okteva, Sandostatin
Portugal · Octreotido Color, Octreotido Depot Teva
Romania · Octreotidă Rompharm, Octreotidă Teva
Slovenia · Oktreotid Teva, Sandostatin
Slovakia · Sandostatin, Sandostatin Lar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cc8b2242-e002-431b-8350-fc6b668cc8bb
GET /v1/drugs/cc8b2242-e002-431b-8350-fc6b668cc8bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20171102000145",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20171102000145",
  "product_doc_link": "https://docetp.mpa.se/LMF/Octreotide%20Teva%20powder%20and%20solvent%20for%20prolonged-release%20suspension%20for%20injection%20SmPC_09001bee81e105c1.pdf"
}

API reference MCP server Plans

See everything about octreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console